Sequent Scientific Limited Detail
Sequent Scientific Limited is in portfolio of Satpal Khattar. He is one of the top investors in India. The company belongs to Pharmaceutical sector.
As per the Company website it an integrated pharmaceutical company with a global footprint, operating in the domains of Animal Health (API and formulation). It has branded Animal Health business as Alivira Animal Health.
The Company has segregated its operations under two heads as mentioned below. It has eight manufacturing facilities spread across world in countries like Germany, Spain, Turkey, Brazil and India.
- Alivira Animal Health
- It is India’s largest and 1st global animal health company offering APIs and formulations.
- The API business is characterised by long established relationships with Global Top 10 Animal Health companies.
- It has a formulations footprint in 80+ countries with 500+ formulations in 12 dosage forms.
- Analytical Solutions
- is a leading Contract Research Organization specialized in Analytical and Bio Analytical Services to support the API, Pharmaceutical, Personal Care and Nutraceutical companies.
I have shared long term price performance chart of the Company below.As per Dow theory of technical analysis price performance over a period of time reflects Company state.
Sequent Scientific Limited Stock Performance
The stock is a multi bagger giving more than 100 times return in above long term chart. Even after recent fall from 250 odd levels to 50 odd levels the stock has given excellent returns in long term.
It was Penny stock back in year 2002 trading below 1 INR mark. For most of the time the stock traded below 50 INR mark. It only crossed this price point in year 2015 and zoomed past 250 mark.
This was the time most Pharma stocks were impacted by USFDA regulations and traded at multi year low or made new lows. The recent big hills impacted overall graph but if you see closely most of the time it gave decent returns.
Sequent Scientific Limited My Opinion
Sequent Scientific Limited is an Pharma Company. It is mainly in business of Animal API. This separates it from other Companies in Pharma space of India. Most of the Pharma Companies in India are in API business of Humans. This is totally dedicated to Animal health API business.
This niche focus from the Company differentiates it from other Companies in Indian pharma space. Though the Company has put all its animal api and formulation business under separate subsidiary entity.
The main company retained business of Analytical solutions. The Animal API is main business of the Company. The recent melt down in Pharma Sector has given good opportunity for investors to pick up quality Pharma Companies.
I have already invested in Pharma space and is willing to increase my exposure in it. I will be tracking this Company as Animal API business looks good to me. I will track to get more idea about products and Company development before making any decision.
In case you are interested then you can track the company by adding it to your stock watch list. That way you can keep close eye on the Company.